Naproflurane 250

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Naproflurane 250 contains sevoflurane, a volatile inhalational general anaesthetic. Its labelling describes it as providing complete loss of sensation, including unconsciousness, during surgical operations, so procedures can be carried out without pain or distress. It is described as helping induce and maintain general anaesthesia while stabilising heart activity, allowing a controllable depth of anaesthesia, and causing low airway irritation. It is administered by a healthcare provider and is not for use without a prescription.

Active ingredient
Sevoflurane
Strength
250 mL
Dosage form
Inhalation vapour, liquid
Therapeutic class
Inhalational general anaesthetic (volatile)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for inducing unconsciousness for surgical or other procedures
  • Described for inducing and maintaining general anaesthesia
  • Described as stabilising heart activity, allowing controllable anaesthetic depth, and causing low airway irritation
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Administered by a healthcare provider
  • Not to be used without a prescription
  • The anaesthetic depth is titrated by the anaesthesia team during the procedure

Described Side Effects

The product description does not list specific side effects. Effects reported for this class of inhalational anaesthetic include:

  • Low blood pressure during administration
  • Changes in heart rate
  • Nausea or vomiting after the procedure

Administration takes place under continuous monitoring by the anaesthesia team; any severe reaction is managed immediately.

Precautions

  • Stored at room temperature (20°C to 25°C), away from moisture, heat, and light
  • Must not be frozen
  • Kept away from the reach of children

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains sevoflurane and is used for inducing and maintaining general anaesthesia for surgical or other procedures. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as administered by a healthcare provider and not for use without a prescription, with anaesthetic depth titrated by the anaesthesia team.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services